The Food and Drug Administration (FDA) has eliminated its Division of Learning and Organizational Development (DLOD), laying off over 30 employees. This decision, part of a broader HHS restructuring under Robert F. Kennedy Jr., impacts FDA staff and external healthcare professionals' training on public health, regulations, and safety. While HHS claims the cuts won't affect inspectors or reviewers, concerns exist about the loss of key public health expertise and the disruption to continuing education programs crucial for maintaining healthcare professional credentials. The elimination of the DLOD's continuing education accreditation team, funded by user fees, raises further questions about the rationale behind the cuts.

Prepared by Olivia Bennett and reviewed by editorial team.